[1] T. Standage, “Social Networking in the 1600s,” New York Times, 2013. http://www.nytimes.com/2013/06/23/opinion/sunday/social-networking-in-the-1600s.html?pagewanted=all&_r=0
[2] A. Mitchell, T. Rosenstiel and L. Christian, “Mobile Devices and News Consumption: Some Good Signs for Journalism|State of the Media,” The State of the News Media 2013. http://stateofthemedia.org/2012/mobile-devices-and-news-consumption-some-good-signs-for-journalism/
[3] R. Cachia, “Social Computing?: Study on the Use and Impact of Online Social Networking,” 2008. http://ipts.jrc.ec.europa.eu/publications/pub.cfm?id=1884
[4] S. Terry and P. Terry, “Power to the People: Participant Ownership of Clinical Trial Data,” Science Translational Medicine, Vol. 3, No. 69, 2011, pp. 1-4. http://dx.doi.org/10.1126/scitranslmed.3001857
[5] “Definition and Benefits of Electronic Medical Records (EMR)|Providers & Professionals|HealthIT.gov,” HealthIT.gov. The Official Site for Health IT Information, 2013. http://www.healthit.gov/providers-professionals/electronic-medical-records-emr
[6] Reuters, “Hospitals Speed Transition to Electronic Medical Records, Study Says,” Breaking News and Opinion on the Huffington Post, 2013. http://www.huffingtonpost.com/2013/07/08/hospitals-digital-electronic-medical-records-transition_n_3563071.html
[7] M. P. Coutinho and F. F. Costa, “Social Media in Science and Medicine,” G.I.T. Laboratory Journal, Vol. 7, 2011, pp. 10-12.
[8] F. F. Costa, “Big Data in Biomedicine,” Drug Discovery Today, 2013, in Press. http://dx.doi.org/10.1016/j.drudis.2013.10.012
[9] K. Miller, “Big Data Analytics in Biomedical Research,” Biomedical Computation Review, 2012, pp. 14-21. http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Big+data+analytics+in+Biomedical+Reseach#2
[10] B. Malin, K. El Emam and C. O’Keefe, “Biomedical Data Privacy: Problems, Perspectives, and Recent Advances,” Journal of the American Medical Informatics Association, Vol. 20, No. 1, 2013, pp. 2-7. http://dx.doi.org/10.1136/amiajnl-2012-001509
[11] K. Mandl and I. Kohane, “Escaping the EHR Trap—The Future of Health IT,” New England Journal of Medicine, Vol. 366, 2012, pp. 2240-2242. http://dx.doi.org/10.1056/NEJMp1203102
[12] M. E. Frisse, K. B. Johnson, H. Nian, C. L. Davison, C. S. Gadd, et al., “The Financial Impact of Health Information Exchange on Emergency Department Care,” Journal of the American Medical Informatics Association, Vol. 10, 2011, pp. 1-6.
[13] F. F. Costa, L. S. Foly and M. P. Coutinho, “DataGenno: Building a New Tool to Bridge Molecular and Clinical Genetics,” The Application of Clinical Genetics, Vol. 4, 2011, pp. 45-54. http://dx.doi.org/10.2147/TACG.S17597
[14] F. F. Costa, “Social Networks, Web-Based Tools and Diseases: Implications for Biomedical Research,” Drug Discovery Today, Vol. 18, No. 5-6, 2013, pp. 272-281. http://dx.doi.org/10.1016/j.drudis.2012.10.006
[15] W. T. Kerr, E. P. Lau and G. E. Owens, “The Future of Medical Diagnostics: Large Digitized Databases,” Yale Journal of Biology and Medicine, Vol. 85, No. 3, 2012, pp. 363-377.
[16] Pricewaterhouse Coopers, “Joining the Conversation: Life Science Industry Ventures into Social Media Despite Regulatory Uncertainty,” Knowledge Line, 2011.
[17] S. Blank, “Why the Lean Start-Up Changes Everything,” Harvard Business Review, 2013. http://hbr.org/2013/05/why-the-lean-start-up-changes-everything
[18] T. C. Norman, C. Bountra, A. M. Edwards, K. R. Yamamoto and S. H. Friend, “Leveraging Crowd Sourcing to Facilitate the Discovery of New Medicines,” Science Translational Medicine, Vol. 3, No. 88, 2011, p. 88. http://dx.doi.org/10.1126/scitranslmed.3002678
[19] M. Anderson, “No Time to Waste,” Science Translational Medicine, Vol. 5, 2013.
[20] P. Keckley and M. Hoffmann, “Social Networks in Health Care: Communication, Collaboration and Insights,” Deloitte, 2010. http://www.healthcarevisions.snapmonkey.net/f/2010_Deliotte_Social_Networks.pdf
[21] T. Hisey, C. Franck and M. Hoffmann, “To Friend or Not?? New Insights about Social Networks in the Life Sciences Industry,” Deloitte, 2010. http://www.deloitte.com/assets/Dcom-Mexico/Local%20Assets/Documents/mx(es-mx)Social%20Networking%20in%20Life%20Sciences_2010.pdf
[22] L. Thompson, et al., “Protected Health Information on Social Networking Sites: Ethical and Legal Considerations,” Journal of Medical Internet Research, Vol. 13, No. 1, 2011, p. e8. http://dx.doi.org/10.2196/jmir.1590
[23] S. Terry and P. Terry, “Power to the People: Participant Ownership of Clinical Trial Data,” Science Translational Medicine, Vol. 3, No. 69, 2011, pp. 1-4. http://dx.doi.org/10.1126/scitranslmed.3001857
[24] V. A. Fusaro, P. Patil, E. Gafni, D. P. Wall and P. J. Tonellato, “Biomedical Cloud Computing with Amazon Web Services,” PLoS Computational Biology, Vol. 7, No. 8, 2011, Article ID: e1002147. http://dx.doi.org/10.1371/journal.pcbi.1002147
[25] “Personalized Medicine,” US News & World Report, 2011. http://health.usnews.com/health-conditions/cancer/personalized-medicine
[26] F. F. Costa, “Genomics, Epigenomics and Personalized Medicine,” BioForum Europe, 2009, pp. 2-4. http://genomicenterprise.com/yahoo_site_admin/assets/docs/Costa_BFE1109-1.203215611.pdf
[27] ACMG Board of Directors, “Points to Consider in the Clinical Application of Genomic Sequencing,” Genetics in Medicine, Vol. 14, No. 8, 2012, pp. 759-761. http://dx.doi.org/10.1038/gim.2012.74
[28] M. Najafzadeh, L. D. Lynd, J. C. Davis, S. Bryan, A. Anis, M. Marra and C. A. Marra, “Barriers to Integrating Personalized Medicine into Clinical Practice: A Best- Worst Scaling Choice Experiment,” Genetics in Medicine, Vol. 14, No. 5, 2012, pp. 520-526. http://dx.doi.org/10.1038/gim.2011.26